Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
09 02 2021
Historique:
received: 06 01 2020
revised: 13 12 2020
accepted: 14 12 2020
pubmed: 16 1 2021
medline: 30 11 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

The bile salt export pump (BSEP) is responsible for the export of bile acid from hepatocytes. Impaired transcellular transport of bile acids in hepatocytes with mutations in BSEP causes cholestasis. Compensatory mechanisms to regulate the intracellular bile acid concentration in human hepatocytes with BSEP deficiency remain unclear. To define pathways that prevent cytotoxic accumulation of bile acid in hepatocytes, we developed a human induced pluripotent stem cell-based model of isogenic BSEP-deficient hepatocytes in a Transwell culture system. Induced hepatocytes (i-Heps) exhibited defects in the apical export of bile acids but maintained a low intracellular bile acid concentration by inducing basolateral export. Modeling the autoregulation of bile acids on hepatocytes, we found that BSEP-deficient i-Heps suppressed de novo bile acid synthesis using the FXR pathway via basolateral uptake and export without apical export. These observations inform the development of therapeutic targets to reduce the overall bile acid pool in patients with BSEP deficiency.

Identifiants

pubmed: 33450190
pii: S2213-6711(20)30503-8
doi: 10.1016/j.stemcr.2020.12.008
pmc: PMC7878720
pii:
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 11 0
Bile Acids and Salts 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-323

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK107553
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK120765
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK078392
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107530
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123181
Pays : United States

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

J Biol Chem. 2012 Jun 15;287(25):21233-43
pubmed: 22535958
Sci Rep. 2017 Feb 02;7:41806
pubmed: 28150711
Mol Pharm. 2016 Apr 4;13(4):1206-16
pubmed: 26910619
Pediatr Dev Pathol. 2004 Jul-Aug;7(4):315-34
pubmed: 15383928
J Pathol. 2012 Jan;226(2):300-15
pubmed: 21984474
Hepatology. 2005 May;41(5):1160-72
pubmed: 15841457
Gastroenterology. 1999 Dec;117(6):1370-9
pubmed: 10579978
J Pharm Sci. 2011 Nov;100(11):5018-30
pubmed: 21837650
Hepatology. 2003 Dec;38(6):1489-99
pubmed: 14647060
Gastroenterology. 2018 Nov;155(5):1578-1592.e16
pubmed: 30063921
Front Biosci (Landmark Ed). 2009 Jan 01;14:2829-44
pubmed: 19273238
Liver Int. 2007 Sep;27(7):920-9
pubmed: 17696930
Pharm Res. 2007 Oct;24(10):1803-23
pubmed: 17404808
Semin Liver Dis. 2011 Feb;31(1):3-10
pubmed: 21344347
Nat Genet. 1998 Nov;20(3):233-8
pubmed: 9806540
Mol Aspects Med. 2013 Apr-Jun;34(2-3):683-92
pubmed: 23506901
J Biol Chem. 2006 Oct 13;281(41):30326-35
pubmed: 16877380
Hepatology. 2018 Apr;67(4):1531-1545
pubmed: 29091294
Mol Pharm. 2019 Jan 7;16(1):238-246
pubmed: 30481467
J Pharmacol Exp Ther. 2015 Feb;352(2):281-90
pubmed: 25467130
Development. 2017 Mar 15;144(6):1056-1064
pubmed: 28275009
Hepatology. 2006 May;43(5):1013-21
pubmed: 16628672
Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1091-1099
pubmed: 27589928
Hepatol Commun. 2017 Oct 12;1(10):1058-1069
pubmed: 29404442
Gastroenterology. 2008 Apr;134(4):1203-14
pubmed: 18395098
Biochem Pharmacol. 2014 Sep 1;91(1):97-108
pubmed: 24973542

Auteurs

Hisamitsu Hayashi (H)

Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

Shuhei Osaka (S)

Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

Kokoro Sakabe (K)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Aiko Fukami (A)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Eriko Kishimoto (E)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Eitaro Aihara (E)

College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Yusuke Sabu (Y)

Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

Ayumu Mizutani (A)

Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

Hiroyuki Kusuhara (H)

Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.

Nakayuki Naritaka (N)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Wujuan Zhang (W)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Stacey S Huppert (SS)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Masahide Sakabe (M)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Takahisa Nakamura (T)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Yueh-Chiang Hu (YC)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Christopher Mayhew (C)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Kenneth Setchell (K)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Takanori Takebe (T)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA; Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.

Akihiro Asai (A)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; College of Medicine, University of Cincinnati, Cincinnati, OH, USA. Electronic address: Akihiro.asai@cchmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH